Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy

Starting soon · Not applicable · Has a placebo group

Conditions studied: Rosacea, Erythematotelangiectatic, Rosacea Subtype 1 (Erythematotelangiectatic)

In brief

The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea. Investigators will compare the dermocosmetic product to a placebo applied to opposite sides of the face, when used alone and in combination with laser treatment. Participants will apply the products twice daily for 2 month followed by continued use in combination with laser treatment, and will attend regular clinical visits for assessments and questionnaires.

Key facts

Study ID
NCT07521462
Run by
ISISPHARMA
People needed
50
Starts
2026-09-01
Expected to finish
2027-06-30
Last updated by the study team
2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.